According to XYZResearch study, over the next five years the Biosimilars Treatmentmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilars Treatmentbusiness.
Biosimilars Treatment market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO. The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Biosimilars Treatment for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Biosimilars Treatment market competition by top manufacturers/players, with Biosimilars Treatment sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Bayer
Eli Lily, Inc.
Pfizer, Inc.
Sandoz International GmbH
Teva Pharmaceutical Industries Limited
Amgen Inc.
Biocon
Dr. Reddy's Laboratories
Roche Ltd.
Celltrion, Inc.
Samsung Bioepis
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Recombinant Non - Glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biosimilars Treatment for each application, including
Oncology
Chronic and Autoimmune Disease
Blood Disorders
Growth Hormone Disease
Infectious Disease
Feel free to let me know if you have any special requirements.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Biosimilars Treatment Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Recombinant Non - Glycosylated Proteins
2.1.2 Recombinant Glycosylated Proteins
2.1.3 Recombinant Peptides
2.2 Overall Market Performance(Value)
2.2.1 Recombinant Non - Glycosylated Proteins
2.2.2 Recombinant Glycosylated Proteins
2.2.3 Recombinant Peptides
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Oncology
3.1.2 Chronic and Autoimmune Disease
3.1.3 Blood Disorders
3.1.4 Growth Hormone Disease
3.1.5 Infectious Disease
4 Manufacturers Profiles/Analysis
4.1 Bayer
4.1.1 Bayer Profiles
4.1.2 Bayer Product Information
4.1.3 Bayer Biosimilars Treatment Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Bayer SWOT Analysis
4.2 Eli Lily, Inc.
4.2.1 Eli Lily, Inc. Profiles
4.2.2 Eli Lily, Inc. Product Information
4.2.3 Eli Lily, Inc. Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Eli Lily, Inc. SWOT Analysis
4.3 Pfizer, Inc.
4.3.1 Pfizer, Inc. Profiles
4.3.2 Pfizer, Inc. Product Information
4.3.3 Pfizer, Inc. Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Pfizer, Inc. SWOT Analysis
4.4 Sandoz International GmbH
4.4.1 Sandoz International GmbH Profiles
4.4.2 Sandoz International GmbH Product Information
4.4.3 Sandoz International GmbH Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Sandoz International GmbH SWOT Analysis
4.5 Teva Pharmaceutical Industries Limited
4.5.1 Teva Pharmaceutical Industries Limited Profiles
4.5.2 Teva Pharmaceutical Industries Limited Product Information
4.5.3 Teva Pharmaceutical Industries Limited Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Teva Pharmaceutical Industries Limited SWOT Analysis
4.6 Amgen Inc.
4.6.1 Amgen Inc. Profiles
4.6.2 Amgen Inc. Product Information
4.6.3 Amgen Inc. Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Amgen Inc. SWOT Analysis
4.7 Biocon
4.7.1 Biocon Profiles
4.7.2 Biocon Product Information
4.7.3 Biocon Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Biocon SWOT Analysis
4.8 Dr. Reddy's Laboratories
4.8.1 Dr. Reddy's Laboratories Profiles
4.8.2 Dr. Reddy's Laboratories Product Information
4.8.3 Dr. Reddy's Laboratories Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Dr. Reddy's Laboratories SWOT Analysis
4.9 Roche Ltd.
4.9.1 Roche Ltd. Profiles
4.9.2 Roche Ltd. Product Information
4.9.3 Roche Ltd. Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Roche Ltd. SWOT Analysis
4.10 Celltrion, Inc.
4.10.1 Celltrion, Inc. Profiles
4.10.2 Celltrion, Inc. Product Information
4.10.3 Celltrion, Inc. Biosimilars TreatmentSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Celltrion, Inc. SWOT Analysis
4.11 Samsung Bioepis
5 Market Performance for Manufacturers
5.1 Global Biosimilars Treatment Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Biosimilars Treatment Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Biosimilars Treatment Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Biosimilars Treatment Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Biosimilars Treatment Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Biosimilars Treatment Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Biosimilars Treatment Market Assessment by Regions (2014-2020)
7.1 Global Biosimilars Treatment Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Biosimilars Treatment Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Biosimilars Treatment Price (USD/Unit) by Regions 2014-2020
7.4 Global Biosimilars Treatment Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Biosimilars Treatment Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Oncology Industry
11.2 Chronic and Autoimmune Disease Industry
11.3 Blood Disorders Industry
11.4 Growth Hormone Disease Industry
11.5 Infectious Disease Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Biosimilars Treatment Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Biosimilars Treatment Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Biosimilars Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Recombinant Non - Glycosylated Proteins
12.2.3 Recombinant Glycosylated Proteins
12.2.4 Recombinant Peptides
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Oncology
12.3.3 Chronic and Autoimmune Disease
12.3.4 Blood Disorders
12.3.5 Growth Hormone Disease
12.3.6 Infectious Disease
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Biosimilars Treatment Price (USD/Unit) Trend 2021-2026
12.4.2 Global Biosimilars Treatment Gross Profit Trend 2021-2026
13 Conclusion
The Zero Liquid Discharge (ZLD) Brine Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
Executive Summary
Azoth Analytics has released a research report titled "Global Classic Car Insurance Market (2024 Edition)" which provides a complete analysis of the Global Classic Car Insurance industry in terms of market segmentation By Vehicle Type (Vintage, and Classic), By Ownersh...
Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type (Medicines, Surgical Procedures, and Assisted Conception), Channel (Fertility Clinics, Hospitals, Research Institutes, and Others), Services (IVF, Genetic Testing, and Reproductive Tissue Storage and D...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
The Industrial Flue Gas Treatment Systems & Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competiti...
The Automotive Parts Heat Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Automatic Sales Enablement System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Heavy Metal Wastewater Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Stainless Steel Surface Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Semiconductor Anodizing Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...